Meeting
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
Authors
Katherine E Poruk
Cancer Treatment Centers of America, Part of City of Hope, Newnan, GA
Katherine E Poruk , Amber Moran , Vicki Doctor , Julia Andrea Elvin , Saba Radhi , Arturo Loaiza-Bonilla , Julian C. Schink , Maurie Markman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4139)
DOI
10.1200/JCO.2022.40.16_suppl.4139
Abstract #
4139
Poster Bd #
125
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2022 ASCO Annual Meeting
Molecular characterization of long-term and short-term survivors of advanced pancreatic ductal adenocarcinoma.
First Author: Jesús Fuentes Antrás